Medicine & Life Sciences

1. Immunoglobulin Light-chain Amyloidosis 100%
2. Multiple Myeloma 99%
3. Amyloidosis 81%
4. Stem Cell Transplantation 43%
5. Waldenstrom Macroglobulinemia 40%
6. Survival 36%
7. Light 30%
8. Plasma Cells 29%
9. Amyloid 24%
10. Transplants 21%
11. Therapeutics 19%
12. Dexamethasone 18%
13. Lenalidomide 17%
14. Melphalan 17%
15. Amyloidosis, Hereditary, Transthyretin-Related 15%
16. Stem Cells 15%
17. Smoldering Multiple Myeloma 14%
18. Immunoglobulin Light Chains 13%
19. Bone Marrow 12%
20. Bortezomib 12%
21. Paraproteinemias 11%
22. Kidney 11%
23. Progression-Free Survival 11%
24. Immunoglobulin M 10%
25. Thalidomide 10%
26. Serum 9%
27. Drug Therapy 8%
28. POEMS Syndrome 8%
29. Monoclonal Gammopathy of Undetermined Significance 8%
30. Biopsy 8%
31. Transplantation 8%
32. Prealbumin 8%
33. Rituximab 8%
34. Familial Amyloidosis 7%
35. Cyclophosphamide 7%
36. Bone Marrow Cells 7%
37. Peripheral Blood Stem Cell Transplantation 6%
38. Hematopoietic Stem Cell Mobilization 6%
39. Cytogenetics 6%
40. Proteins 6%
41. Peripheral Blood Stem Cells 6%
42. Clinical Trials 6%
43. Hematopoietic Stem Cell Transplantation 5%
44. Amyloid Plaques 5%
45. Mortality 5%
46. Fluorescence In Situ Hybridization 5%
47. pomalidomide 5%
48. Troponin T 5%
49. Recurrence 5%
50. Immunoglobulins 5%